Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

F Lo Coco - Leukemia, 2002 - nature.com
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia.

D Grimwade - Leukemia, 2002 - europepmc.org
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

D Grimwade, FL Coco - Leukemia, 2002 - go.gale.com
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia.

D Grimwade, F Lo Coco - Leukemia (08876924), 2002 - search.ebscohost.com
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

D Grimwade, FL Coco - Leukemia, 2002 - kclpure.kcl.ac.uk
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

[引用][C] Acute promyelocytic leukemia: a mode for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid …

D GRIMWADE - Leukemia, 2002 - cir.nii.ac.jp
Acute promyelocytic leukemia : a mode for the role of molecular diagnosis and residual disease
monitoring in directing treatment approach in acute myeloid leukemia | CiNii Research CiNii …

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

D Grimwade, FL Coco - Leukemia, 2002 - pubmed.ncbi.nlm.nih.gov
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

Acute promyelocytic leukemia: A model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

D Grimwade, F LO COCO - LEUKEMIA, 2002 - art.torvergata.it
Acute promyelocytic leukemia (APL) is characterized by a number of features that underpin
the need for rapid and accurate diagnosis and demand a highly specific treatment approach …

[引用][C] Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid …

D GRIMWADE - Leukemia, 2002 - cir.nii.ac.jp
Acute promyelocytic leukemia : a model for the role of molecular diagnosis and residual
disease monitoring in directing treatment approach in acute myeloid leukemia | CiNii Research …

[引用][C] Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid …

D Grimwade, FL Coco - Leukemia, 2002 - Nature Publishing Group